Reliability and Validity of a New Postoperative Track Assessment Tool

University Hospital, Geneva879 enrolled

Overview

This prospective observational study investigated the validity and reliability of a new postoperative track assessment tool. We hypothesized, first, that this tool estimates the indication and benefit of a management in an intermediate care unit (IMC). Second, we hypothesized that a) health care providers of IMC or postoperative anaesthesia care unit (PACU) have similar estimations using this tool and b) that this estimation is accurately established in the first 2 hours.

The tool includes 2 visual analog scale (VAS) scores estimating indication of an IMC admission and benefit of an IMC stay. The tool was tested in a PACU and in an IMC unit of a Swiss tertiary centre in 2019/2020 (before COVID pandemic). Three raters: one nurse, one physician in charge and the consultant physician, were asked to fill the VAS at the same time for each included patient. The score was done in the 2 first hours following admission in the unit and during the multi professional morning round at day 1. Reliability was estimated by testing internal consistency (homogeneity), interrater reliability and agreement and test-retest validity (stability). Validity included content validity, construct validity and criterion validity.

Study Type

OBSERVATIONAL

Enrollment

879

Conditions

Perioperative Complication

Interventions

Po Tra toolOTHER

Healthcare workers filled the 2 VAS of the tool but it did not impact or change the care of the patient. (observational)

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * PACU patients admitted on Mondays * IMC patients admitted 7:30am-7:30pm on weekdays Exclusion Criteria: * night admission * PACU patient ASA \< 3 or minor intervention

Locations (1)

Geneva University Hospital

Geneva, Switzerland

Outcomes

Primary Outcomes

Intermediate Care (IMC) indication (VASi)

Health care raters graded the IMC indication (or allocative efficiency) for each patient on a visual analog scale grading from 0 (very low indication of an IMC management) to 100 (very high indication of an IMC management), namely VASi.

Time frame: 2019/2020

Intermediate Care benefit (VASb)

Health care raters graded the IMC benefit (or health gain) for each patient on a visual analog scale grading from 0 (very low benefit from an IMC management) to 100 (very high benefit from an IMC management), namely VASb.

Time frame: 2019/2020

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.